Sign Up Today and Learn More About CardioFocus Stock
Invest in or calculate the value of your shares in CardioFocus or other pre-IPO companies through EquityZen's platform.
CardioFocus Stock (CAFO)
CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders.
About CardioFocus Stock
Founded
1990
Headquarters
Marlborough, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders. The company specializes in providing electrophysiologists with innovative and effective tools that bring new levels of precision and control to the treatment of atrial fibrillation that focuses on developing, manufacturing, and investigating disposable fiber optic catheters for the visualization of the cardiac anatomy and the treatment of cardiac arrhythmias. CardioFocus was founded in 1990 and is headquartered in Marlborough, Massachusetts.
CardioFocus Management
Leadership team at CardioFocus
CEO & Board Member
Burke T Barrett
Executive Chairman
Paul LaViolette
Join now and verify your accreditation status to gain access to:
- CardioFocus current valuation
- CardioFocus stock price
- Available deals in CardioFocus and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in CardioFocus stock?
Accredited investors can buy pre-IPO stock in companies like CardioFocus through EquityZen funds. These investments are made available by existing CardioFocus shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell CardioFocus stock?
Shareholders can sell their CardioFocus stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
